Glanzmann Thrombasthenia

What is Glanzmann thrombasthenia?

Glanzmann thrombasthenia is a rare inherited bleeding disorder in which platelets do not work properly. Platelets are small cell fragments in the blood that clump together to plug a damaged blood vessel. In glanzmann thrombasthenia the platelets are usually present in normal numbers and look normal, but they are missing or have a faulty version of a surface protein they need to stick to each other. As a result, bleeding lasts longer than expected after an injury, and bleeding can sometimes start without an obvious cause.

The condition is present from birth and lasts for life. It affects males and females equally. It is considered very rare worldwide, although it is reported more often in communities where marriage between close relatives is common, because the condition is passed on when a child inherits a changed gene from both parents. Glanzmann thrombasthenia is different from hemophilia, which involves clotting factors (proteins dissolved in the blood) rather than platelets, and it is also different from conditions in which the platelet count is low.

Care for this condition is usually coordinated by a hematologist, a doctor who specializes in blood disorders. At Acibadem, patients with inherited platelet disorders are typically managed within the Hematology Department, often together with other specialists when surgery, dental work or pregnancy is planned.

Symptoms of glanzmann thrombasthenia

Glanzmann thrombasthenia symptoms are mostly related to bleeding from the skin and mucous membranes, which are the moist linings of the nose, mouth, gut and reproductive tract. Bleeding into joints and muscles, which is typical of hemophilia, is uncommon in this condition. Common symptoms include:

• Easy or unexplained bruising, sometimes with large bruises after minor bumps
• Frequent or prolonged nosebleeds (epistaxis), which can be hard to stop
• Bleeding from the gums, especially when brushing teeth or after dental work
• Small red or purple dots on the skin called petechiae, caused by tiny bleeds under the skin
• Heavy or prolonged menstrual periods (menorrhagia) in women and girls
• Bleeding that continues for a long time after cuts, scrapes, injections or tooth extraction
• Excessive bleeding during or after surgery or childbirth
• Blood in the stool or vomit, which may signal bleeding in the digestive tract
• Tiredness, pale skin or shortness of breath caused by iron-deficiency anemia (a shortage of red blood cells) after repeated blood loss

Symptoms often appear early in life. Many babies and young children are first noticed to bruise easily, have prolonged bleeding from the umbilical cord stump, or have nosebleeds that are difficult to control. In girls, the first menstrual period can be unusually heavy and may be the event that leads to diagnosis if it has not been made earlier.

Doctors sometimes describe glanzmann thrombasthenia by type, based on how much of the missing platelet protein is present. In type I, the protein is almost completely absent. In type II, a reduced amount is present. In the variant type, the protein is present in near-normal amounts but does not function correctly. In practice, the type does not reliably predict how severe the bleeding will be. Some people with the same type have frequent, serious bleeding while others have only mild symptoms, and bleeding tendency can vary within one person over time.

Causes and risk factors

Glanzmann thrombasthenia causes are genetic. The condition is caused by changes (mutations) in one of two genes, called ITGA2B and ITGB3. These genes carry the instructions for making two protein parts that join together on the platelet surface to form a receptor known as glycoprotein IIb/IIIa, also called integrin alpha-IIb beta-3. This receptor acts like a hook. When a blood vessel is injured, it grabs a blood protein called fibrinogen, which links platelets to one another so they can form a plug. When the receptor is missing or faulty, platelets can still reach the site of injury but cannot bind firmly to each other, and the plug does not form properly.

The condition is inherited in an autosomal recessive pattern. This means a person must receive one changed copy of the gene from each parent to develop the disorder. Parents who each carry a single changed copy usually have no bleeding symptoms themselves and are often unaware they are carriers. When both parents are carriers, each pregnancy has a one-in-four chance of producing a child with the condition.

Recognized risk factors include:

• Having parents who are both carriers of a change in ITGA2B or ITGB3
• A family history of glanzmann thrombasthenia or of unexplained bleeding in relatives
• Parents who are closely related to each other, which raises the chance that both carry the same rare gene change
• Belonging to a community in which the condition is known to be more common

Glanzmann thrombasthenia is not caused by diet, lifestyle, infection or anything a parent did during pregnancy. It is not contagious. A rare acquired form, in which the immune system makes antibodies that block the platelet receptor, has been described in adults with certain blood or immune conditions, but this is distinct from the inherited disorder and is considered separately by doctors.

Diagnosis of glanzmann thrombasthenia

Glanzmann thrombasthenia diagnosis usually begins with a careful history of bleeding episodes and a family history, followed by laboratory tests. Because the condition is rare, it is often suspected only after more common bleeding disorders have been considered. The main steps typically include:

• Complete blood count (CBC): a routine blood test that measures the number of platelets and red blood cells. In glanzmann thrombasthenia the platelet count is usually normal, which helps distinguish it from conditions where platelets are simply low. The test may also show anemia from blood loss.
• Blood smear: a drop of blood examined under a microscope. Platelet size and appearance are usually normal.
• Clotting factor tests: tests such as prothrombin time and activated partial thromboplastin time, which measure the clotting proteins. These are usually normal, which helps rule out hemophilia and similar disorders.
• Von Willebrand testing: von Willebrand disease is a more common bleeding disorder that can cause similar symptoms and is often checked and excluded first.
• Platelet function screening: tests that measure how quickly platelets close a small opening under flow conditions. In glanzmann thrombasthenia the closure time is typically very prolonged.
• Platelet aggregation studies: the key laboratory test. Platelets are exposed to several chemicals that normally make them clump. In glanzmann thrombasthenia, platelets fail to aggregate in response to almost all of these agents, while the response to one particular agent, ristocetin, is usually preserved. This pattern is highly characteristic.
• Flow cytometry: a technique that uses labeled antibodies to count the glycoprotein IIb/IIIa receptors on the platelet surface. It confirms whether the receptor is absent, reduced or present but abnormal, and it helps classify the type.
• Genetic testing: analysis of the ITGA2B and ITGB3 genes to identify the specific change. This confirms the diagnosis, allows carrier testing of relatives and can support family planning decisions.

Imaging scans are not needed to diagnose the condition itself, although a doctor may order an ultrasound, endoscopy or other imaging to find the source of bleeding during a specific episode, for example in the digestive tract. Because specialized platelet testing requires fresh blood samples and experienced laboratories, the diagnosis is usually confirmed at a center with a hematology service.

Treatment options for glanzmann thrombasthenia

There is currently no medication that corrects the underlying platelet defect. Glanzmann thrombasthenia treatment therefore focuses on preventing bleeding where possible, stopping bleeding promptly when it occurs and treating the consequences of blood loss. Treatment is tailored to each person and to the type and severity of bleeding.

Local measures. Many minor bleeds can be managed at the site. Firm pressure, nasal packing for nosebleeds, ice, and gelatin sponges or fibrin sealants (glue-like products that help form a clot) applied to a wound are commonly used. Dentists may use special mouth rinses, sutures and protective splints after dental procedures.

Antifibrinolytic medicines. Tranexamic acid and aminocaproic acid slow the breakdown of clots once they have formed. They are frequently used for nosebleeds, gum bleeding, heavy periods and around dental or minor surgical procedures. They may be given as tablets, mouthwash or intravenously depending on the situation.

Hormonal treatment. For heavy menstrual bleeding, doctors may recommend hormonal medicines such as combined oral contraceptives or a hormone-releasing intrauterine device to make periods lighter or stop them. Very heavy bleeding at the first period sometimes requires hospital treatment.

Platelet transfusions. Giving platelets from a donor supplies working receptors and is an effective way to control serious bleeding or to cover major surgery. However, repeated transfusions carry a risk that the body develops antibodies against the donor platelets or against the missing receptor itself, which can make future transfusions less effective. For this reason doctors generally reserve transfusions for significant bleeding and, where available, use platelets matched to the patient.

Recombinant activated factor VII. This is a manufactured clotting protein that helps clots form even when platelets do not aggregate normally. It is approved in many countries for people with glanzmann thrombasthenia who have developed antibodies or who do not respond to platelet transfusions, and it is also used in some centers to prepare for surgery.

Treatment of anemia. Iron supplements, taken by mouth or given intravenously, are often needed to replace iron lost through bleeding. Occasionally a red blood cell transfusion is required after heavy blood loss.

Hematopoietic stem cell transplantation. A transplant of blood-forming stem cells from a donor can replace the patient’s platelet-producing cells with healthy ones and is the only treatment that can potentially cure the condition. Because the procedure carries serious risks, it is generally considered only for people with severe, life-threatening bleeding that cannot be controlled with other measures. Gene therapy is being studied in research settings but is not an established treatment.

Medicines to avoid. People with glanzmann thrombasthenia are usually advised to avoid aspirin, ibuprofen and other nonsteroidal anti-inflammatory drugs, which further weaken platelet function, and to check with their doctor before taking any new medicine or supplement. Acetaminophen (paracetamol) is generally considered a safer choice for pain relief, although any medication should be discussed with the treating team.

Living with glanzmann thrombasthenia and outlook

Glanzmann thrombasthenia is a lifelong condition, but with careful planning many people lead full and active lives. The bleeding tendency does not usually worsen with age, and some people find that nosebleeds become less frequent after childhood. Serious bleeding, including bleeding inside the skull or the digestive tract, is uncommon but can happen, which is why a clear management plan and quick access to care matter.

Practical steps that doctors commonly recommend include:

• Carrying a medical alert card or bracelet stating the diagnosis and the preferred treatment approach
• Keeping a written emergency plan and knowing which hospital can provide platelets and specialist advice
• Telling every dentist, surgeon and anesthesiologist about the condition well before any procedure so that preventive treatment can be arranged
• Maintaining good oral hygiene and regular dental checkups to reduce gum bleeding and the need for extractions
• Choosing physical activities thoughtfully; many sports are possible, while contact sports with a high risk of head injury are usually discouraged
• Receiving vaccinations, including against hepatitis B, since blood products may be needed over a lifetime
• Planning pregnancy with a hematologist and obstetric team, as bleeding at delivery and afterward requires preparation

Regular follow-up with a hematology service allows monitoring for anemia, checking for antibodies that may affect transfusion, and updating the treatment plan as new options become available. Genetic counseling can help families understand inheritance and the options for testing relatives. Children with the condition often benefit from school staff being informed so that nosebleeds and minor injuries are handled calmly and appropriately.

Frequently asked questions

What are the first glanzmann thrombasthenia symptoms in children?

In infants and young children the earliest signs are often easy bruising, prolonged bleeding from the umbilical cord stump or after a heel-prick blood test, and frequent nosebleeds that are hard to stop. Petechiae, the small red dots under the skin, and gum bleeding when teeth come through may also be noticed. Because these signs can overlap with other conditions, a doctor will usually order blood tests before drawing conclusions.

What causes glanzmann thrombasthenia, and can it skip a generation?

The condition is caused by inherited changes in the ITGA2B or ITGB3 genes, which affect the platelet receptor needed for clumping. Because it is recessive, a child develops it only when both parents pass on a changed copy. Carrier parents usually have no symptoms, so the disorder can appear in a family with no previously affected members and may seem to skip generations, even though the gene change has been present all along.

How is glanzmann thrombasthenia diagnosis confirmed?

Diagnosis is typically confirmed by platelet aggregation studies, which show that platelets fail to clump in response to nearly all test agents while responding normally to ristocetin, together with flow cytometry demonstrating absent, reduced or abnormal glycoprotein IIb/IIIa on the platelet surface. Genetic testing identifies the specific gene change and can confirm the result. Standard blood counts and clotting factor tests are usually normal, which is itself an important clue.

Is there a cure for glanzmann thrombasthenia?

There is no medication that cures the condition. Hematopoietic stem cell transplantation can potentially provide a lasting correction because it replaces the cells that make platelets, but it carries significant risks and is generally reserved for people with severe bleeding that cannot be controlled otherwise. For most people, treatment focuses on preventing and controlling bleeding, and many manage well over a lifetime with this approach.

What does glanzmann thrombasthenia treatment involve during surgery or dental work?

Before a planned procedure, the hematology and surgical teams usually agree on a plan that may include antifibrinolytic medicines, platelet transfusion, recombinant activated factor VII, or a combination, depending on the size of the operation and whether the person has antibodies. Local measures such as fibrin sealant and careful surgical technique are also important. Emergency surgery is more difficult to plan for, which is one reason a written emergency plan is recommended.

Can women with glanzmann thrombasthenia have children safely?

Many women with the condition have had successful pregnancies, but pregnancy and delivery need careful planning because bleeding at birth and in the weeks afterward can be significant. A hematologist and an obstetric team experienced in bleeding disorders usually work together to prepare treatments such as platelet transfusion or recombinant activated factor VII for delivery. The baby will not have the condition unless the other parent is also a carrier, but testing may be discussed.

Does glanzmann thrombasthenia get worse with age?

The underlying platelet defect does not change over time, so the condition does not progress in the way some diseases do. Bleeding patterns can shift with life stages; nosebleeds often improve after childhood, while menstrual bleeding becomes a concern for women after puberty. Repeated blood loss can lead to iron deficiency if not treated, and antibodies may develop after multiple transfusions, so ongoing follow-up remains important throughout life.

When to see a doctor

Anyone who has a history of easy bruising, frequent nosebleeds, heavy periods or prolonged bleeding after minor injuries or dental work should discuss these symptoms with a doctor, who can decide whether testing for a bleeding disorder is appropriate. People who already have a diagnosis of glanzmann thrombasthenia should keep regular follow-up appointments and seek advice before any surgery, dental treatment, new medication or pregnancy.

Seek emergency medical care right away if any of the following occur:

• A nosebleed or other bleeding that does not stop after 20 to 30 minutes of firm pressure
• Any head injury, even if it seems minor, or a severe headache, confusion, vomiting, drowsiness or weakness, which can signal bleeding inside the skull
• Vomiting blood, or passing black, tarry or bloody stools
• Coughing up blood or bleeding that causes difficulty breathing or swallowing
• Very heavy menstrual bleeding that soaks through pads every hour or causes dizziness or fainting
• Bleeding after an injury to the abdomen, chest or back, or severe pain in these areas after trauma
• Signs of severe blood loss such as pale skin, rapid heartbeat, faintness or shortness of breath
• Blood in the urine, or bleeding in the eye or sudden loss of vision

When seeking emergency care, it helps to bring the medical alert card or emergency plan and to tell staff immediately that the person has glanzmann thrombasthenia, because the treatment differs from that used for other bleeding conditions.